Cancer-targeted drugs can live for years

For patients with cancer using targeted drug therapy, the specific survival period depends on the pathological type of the patient's disease and the stage of the disease. For patients with early disease stage or tumors with low malignant degree, the survival period of the patient is relatively long. Some patients can reach the survival period of five or six years, or even ten years. However, for some malignant tumors with high malignant degree, the survival time of advanced malignant tumors at this time may not be so long, and the treatment effect is not as good as that of early stage. At this time, patients may be able to reach an extended time of about one year, or a survival period of about two to three years. Therefore, there is no very accurate answer for how many years cancer-targeted drugs can live. It depends on the patient's disease.